The project team working together (from left): Stephan Lynen, head of regional business line, Clariant; Dr Deok-Hoon Park, CEO of BioSpectrum; Christian Vang, head of Clariant BU ICS; Dr Younghyun Kim, head of sales & marketing, BioSpectrum; Guido Appl, head of sales & application, Clariant.
MUTTENZ, GERMANY: Clariant AG said it will acquire a 17 percent share in South Korea-headquartered BioSpectrum Inc, a developer and supplier of specialty active cosmetics’ ingredients derived from Asia’s diverse flora which have proven benefits for humans.
Currently a family-owned business, BioSpectrum will remain an independently managed company. Clariant will leverage its global sales and innovation network to market BioSpectrum’s product portfolio of active ingredients worldwide.
“Our investment in BioSpectrum will give us further access to highly innovative active ingredients based on renewable raw materials. This corresponds to a growing consumer demand for natural cosmetic ingredients, not only in the emerging markets of Asia but worldwide,” said Hariolf Kottmann, CEO of Clariant.
“We will have a strong partner on-board supporting our fast and ambitious expansion plans and we foresee tremendous innovation synergies,” said Dr Deok-Hoon Park, CEO, BioSpectrum.
BioSpectrum’s portfolio of functional ingredients is derived from natural products and extracts from exotic Asian plants, in particular those found on the South Korean Jeju Island – an isolated mountain formed by volcanic eruption and featuring over 1,800 plant species. Its formulation ingredients include active compounds offering moisturizing, whitening, anti-aging, wound healing, anti-acne, skin soothing, anti-inflammation, anti-dandruff, detoxification and body slimming effects.
© Worldofchemicals News
Read the latest news from Clariant:
Clariant launches LTS chloride guard catalyst ShiftGuard 200